Form 4: Sutro Biopharma's Chief Medical Officer Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Anne Elizabeth Borgman, Chief Medical Officer of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.

Summary

  • Anne Elizabeth Borgman, the Chief Medical Officer of Sutro Biopharma, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
  • On February 28, 2025, 37,500 shares of common stock were acquired through the vesting of restricted stock units (RSUs), and 15,405 shares were withheld by the issuer to cover income tax obligations.
  • On March 1, 2025, an additional 11,250 shares were acquired through RSU vesting, with 4,621 shares withheld for tax purposes.
  • Following these transactions, Borgman directly owns 53,098 shares of common stock.
  • She also holds 33,750 RSUs that will vest in the future.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
02/29/2024First vesting date for 1/4th of the February 28, 2025 RSU award.
02/28/2025Date of RSU vesting (37,500 shares) and tax withholding (15,405 shares).
03/01/2025Date of RSU vesting (11,250 shares) and tax withholding (4,621 shares).
03/01/2025First vesting date for 1/4th of the March 1, 2025 RSU award.
03/04/2025Date of Form 4 filing.
02/28/2027Expiration date for the February 28, 2025 RSU award.
03/01/2028Expiration date for the March 1, 2025 RSU award.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.